Katelyn Liles
Medical · Senatobia, MSNPI 1144984451
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 218 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,343 and has fallen 77.3% since, to $305 in 2025.
Across 218 payments — averaging $16.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$647
- AstraZeneca$556
- Novo Nordisk$418
- GSK$390
- Boehringer Ingelheim$267
- Bayer$247
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,694100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 51 | $647 |
| AstraZeneca | 29 | $556 |
| Novo Nordisk | 23 | $418 |
| GSK | 23 | $390 |
| Boehringer Ingelheim | 17 | $267 |
| Bayer | 12 | $247 |
| Lilly USA, LLC | 12 | $213 |
| Pfizer | 11 | $189 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $125 |
| Dexcom, Inc. | 5 | $106 |
| Mylan Specialty L.p. | 3 | $72 |
| Johnson & Johnson | 4 | $67 |
| Amarin Pharma, Inc. | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Sunovion Pharmaceuticals Inc. | 2 | $40 |
| Boston Scientific | 2 | $37 |
| Amgen | 2 | $33 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| Exact Sciences | 2 | $29 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $27 |
| Novartis | 1 | $22 |
| Heartflow, Inc. | 1 | $19 |
| IBSA Pharma Inc. | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $13 |
| Bioventus LLC | 1 | $12 |
How this compares
$3,694 in reported general payments places this provider in the 75th percentile of 65 medical providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 103 | $115,525 |
| OzempicSemaglutide | 54 | $84,075 |
| MounjaroTirzepatide | 44 | $58,255 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 51 | $56,559 |
| EliquisApixaban | 65 | $42,310 |
| FarxigaDapagliflozin Propanediol | 31 | $30,268 |
| JanuviaSitagliptin Phosphate | 32 | $23,267 |
| XareltoRivaroxaban | 14 | $16,142 |
| VascepaIcosapent Ethyl | 22 | $14,909 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 38 | $4,204 |
| Memantine Hcl | 40 | $3,714 |
| Duloxetine Hcl | 153 | $3,590 |
| Rosuvastatin Calcium | 272 | $2,670 |
| Aripiprazole | 32 | $2,424 |
| Gabapentin | 170 | $2,013 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $267 | $115,525103 claims |
| Novo NordiskOzempic | $418 | $84,07554 claims |
| Lilly USA, LLCMounjaro | $213 | $58,25544 claims |
| GSKTrelegy Ellipta | $390 | $56,55951 claims |
| PfizerEliquis | $189 | $42,31065 claims |
| AstraZenecaFarxiga | $556 | $30,26831 claims |
| Johnson & JohnsonXarelto | $67 | $16,14214 claims |
| AbbVieSynthroid | $647 | $1,53317 claims |
| Sanofi-aventis U.S. LLCLantus | $14 | $84815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 65 medical providers in Mississippi.
Other medical in Senatobia
- Shannon YoungerColumbus$63K
- Angela DauroBiloxi$25K
- Jenna HabermanFlowood$14K
- Ashley LarsenOcean Springs$11K
- Elise BuckleyClinton$10K
- Caroline BaldwynMadison$9K
- Miranda SudduthMadison$8K
- Catherine DiazFlowood$7K
- Whitney TrammellMeridian$7K
- Ashley BourgeoisOcean Springs$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.